WGRX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
WGRX is not a good buy right now for an impatient investor. The trend is still bearish (SMA_200 > SMA_20 > SMA_5), there are no Intellectia buy signals today, and there are no near-term news catalysts. While the price is near support and RSI is low-ish (potential for a short bounce), the setup does not justify chasing upside immediately given weak and deteriorating fundamentals in the latest reported quarter (2025/Q3).
Price closed at 0.3588 (+6.98% regular session) but remains below the pivot (0.377), indicating it is still trading under a key decision level. Moving averages are clearly bearish (SMA_200 > SMA_20 > SMA_5), consistent with a downtrend. RSI_6 at 36.6 is weak/near oversold but still technically in the neutral zone, suggesting downside pressure may be easing but not reversed. MACD histogram is slightly positive (0.000368) but contracting, implying bullish momentum is fading rather than accelerating. Key levels: support S1=0.338 (then S2=0.314); resistance R1=0.417 (then R2=0.441). A more convincing buy would typically require reclaiming/holding above ~0.377 and improving momentum.
Intellectia Proprietary Trading Signals
and a relatively low RSI that can sometimes precede short-term bounces; modest statistical bullish bias from pattern study (50% chance of +0.59% next day, +4.49% next week).
Primary trend is bearish (stacked bearish moving averages). Momentum is not convincingly improving (MACD histogram positive but contracting). No recent news catalysts. Trading trends show hedge funds and insiders are neutral (no supportive flow). Financials in 2025/Q3 show sharp revenue decline and very weak margins, which can weigh on sentiment and limit sustainable upside.
Latest quarter: 2025/Q3. Revenue fell to 3,012,904 (-46.90% YoY), indicating a significant contraction in the business. Profitability is very weak: net income was -34,318,204 (a large loss) and EPS was -0.46. Gross margin was -18.98%, meaning the company is operating with severely negative margin structure (worse YoY per provided data). Overall, the quarter shows worsening operating quality and declining top-line growth.
No analyst rating or price target updates were provided in the data. As a result, there is no clear 'Wall Street pros vs cons' consensus available here; the absence of coverage/updates typically removes a common near-term catalyst (upgrades/targets) that could support an impatient buy thesis.
